Spyre Therapeutics, Inc. (SYRE)

71.50 -0.50 (-0.69%) USD  |  NASDAQ  |  Jun 09, 12:53
More

Spyre Therapeutics EBITDA Margin (TTM)

EBITDA Margin (TTM) Chart

View EBITDA Margin (TTM) for SYRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA Margin (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Margin (TTM) Range, Past 5 Years

View EBITDA Margin (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA Margin (TTM) Benchmarks

View EBITDA Margin (TTM) Benchmarks
Start Trial
Praxis Precision Medicines, Inc. --
Viridian Therapeutics, Inc. Upgrade
Relay Therapeutics, Inc. Upgrade
Damora Therapeutics, Inc. --
Savara, Inc. --